Biologics AI Moonshot: Building the Next Generation Digital Biologics Platform
Yves Fomekong Nanfack, Head of End to End AI Foundations, Large Molecules Research Platform, Sanofi
Yves discusses the methods for accelerating and improving the success probability of large molecule discovery. Methods featured include AI-guided hit discovery, industrialization of AI/ML models for biologics design, and democratization of experimental and in silico data access. Yves also highlights the importance of improving researcher efficiency and experience.
- Acceleration of large molecule discovery time and improve probability of success.
- Industrialization of AI/ML models for biologics design and discovery
- Democratization of experimental and in silico data access and enabling AI guided hit discovery
- Improving researcher efficiency and experience through a streamlined process
